Skip to main content
. Author manuscript; available in PMC: 2011 Jan 22.
Published in final edited form as: Vaccine. 2009 Nov 13;28(4):1031. doi: 10.1016/j.vaccine.2009.10.126

Figure 1.

Figure 1

Figure 1

Figure 1

Figure 1

Geometric mean PRN and ELISA titers at Day 21 and 49 post-vaccination with gV3526 with and without adjuvant. All mice were vaccinated on a 2 dose schedule except mice vaccinated with C-84 which were vaccinated with 3 doses. The route of administration in 1a and 1b was IM except for C-84 which was administered SC. The route of vaccination in 1c and 1d was SC. The data in 1a and 1c are reported as the geometric mean endpoint titers that inhibit virus plaque formation by 80% and the data reported in 1b and 1d are the geometric mean endpoint titers of immunoglobulin. Error bars represent the 95% confidence level.